Dianei is a medical artificial intelligence enterprise in precision medicine.
Diane Technology is an innovative medical artificial intelligence enterprise in precision medicine established in April 2016 in Shanghai , dedicated to making early and personalized diagnosis and treatment accessible to each patient. The company's core technical team comes from the Sigma Xi Society and the core management team comes from world's top 10 healthcare companies. Dianei is aim at providing integrated solutions for tumor diagnosis and treatment by leveraging cutting-edge artificial intelligence technology, combining deep learning with big data of muti-omics including radiology, pathology, proteomics, immunology, metabonomics, etc. The products and solutions have been developed for different scenarios such as screening, clinical and new drug development in lung cancer field, involving early screening of lung cancer, benign and malignant determination, preoperative planning and postoperative follow-up, companion diagnostics of targeted drugs and immunodrugs, and evaluation of therapeutic effect of new drug research and development clinical trials. In the future, we will also apply core technology and products to other tumor diseases, and strive to build a leading Al solution for the full management of cancer in China and even in the world, helping doctors and patients improve the efficiency and quality of diagnosis and treatment, transforming patient care with the power of Al.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 1, 2017 | Series Unknown | ¥50M | 1 | Xinyi Investment Fund Management | — | Detail |
Aug 16, 2017 | Angel | ¥3M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Xinyi Investment Fund Management | Yes | Series Unknown |
Huayuan Shuju | — | Angel |
Xinyi Chuangxin Ziben | — | Angel |